Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience.


DEMİR M., DANIŞ N., KANİ H. T. , YILDIRIM A. E. , BALKAN A., DEĞERTEKİN M. B. , ...More

APASL Single Topic Conference, İstanbul, Turkey, 27 - 29 September 2018

  • Publication Type: Conference Paper / Full Text
  • City: İstanbul
  • Country: Turkey